Effective targeting of DC-SIGN by α-fucosylamide functionalized gold nanoparticles.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Bioconjugate chemistry

• Publication date

  2014-11-24

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1021/bc500467uPMID 25379972
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pseudo-Mannosylated DC-SIGN Ligands as Potential Adjuvants for HIV Vaccines

  2014cited by this paper
• Galactofuranose-coated gold nanoparticles elicit a pro-inflammatory response in human monocyte-derived dendritic cells and are recognized by DC-SIGN.

  2014cited by this paper
• Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells.

  2013cited by this paper
• Synthesis and Characterization of Linker-Armed Fucose-Based Glycomimetics

  2013cited by this paper
• Glyconanoparticles as multifunctional and multimodal carbohydrate systems.

  2013cited by this paper
• Glyconanoparticles as Multifunctional and Multimodal Carbohydrate Systems

  2013cited by this paper
• Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.

  2013cited by this paper
• Factors affecting T cell responses induced by fully synthetic glyco-gold-nanoparticles.

  2013cited by this paper
• High Sensitive Detection of Carbohydrate Binding Proteins in an ELISA-Solid Phase Assay Based on Multivalent Glyconanoparticles

  2013cited by this paper
• Strengths and Weaknesses of Immunotherapy for Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of 12 Randomized Controlled Trials

  2012cited by this paper
• Detection and isolation of dendritic cells using Lewis X-functionalized magnetic nanoparticles.

  2012cited by this paper
• A Decade of Imaging Cellular Motility and Interaction Dynamics in the Immune System

  2012cited by this paper
• Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides.

  2012cited by this paper
• Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.

  2012cited by this paper
• Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer.

  2012cited by this paper
• Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin.

  2011cited by this paper
• Multimodal imaging of nanovaccine carriers targeted to human dendritic cells.

  2011cited by this paper
• Helminths and dendritic cells: Sensing and regulating via pattern recognition receptors, Th2 and Treg responses

  2010cited by this paper
• Gold nanoparticle platforms as drug and biomacromolecule delivery systems.

  2010cited by this paper
• Gold nanoparticles: opportunities and challenges in nanomedicine

  2010cited by this paper
• Monovalent and bivalent N-fucosyl amides as high affinity ligands for Pseudomonas aeruginosa PA-IIL lectin.

  2010cited by this paper
• Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity.

  2009cited by this paper
• Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori

  2009cited by this paper
• Signalling through C-type lectin receptors: shaping immune responses

  2009cited by this paper
• Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.

  2009cited by this paper
• Endogenous ligands for C‐type lectin receptors: the true regulators of immune homeostasis

  2009cited by this paper
• Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN.

  2009cited by this paper
• Taking dendritic cells into medicine

  2007cited by this paper
• HIV-1 gp120 Mannoses Induce Immunosuppressive Responses from Dendritic Cells

  2007cited by this paper
• Specificity of DC‐SIGN for mannose‐ and fucose‐containing glycans

  2006cited by this paper
• Dynamic populations of dendritic cell-specific ICAM-3 grabbing nonintegrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes.

  2004cited by this paper
• Gold glyconanoparticles: synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for glycobiological studies.

  2003cited by this paper
• Cutting Edge: Carbohydrate Profiling Identifies New Pathogens That Interact with Dendritic Cell-Specific ICAM-3-Grabbing Nonintegrin on Dendritic Cells

  2003cited by this paper
• The Dendritic Cell-Specific Adhesion Receptor DC-SIGN Internalizes Antigen for Presentation to T Cells1

  2002cited by this paper
• Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo

  2001cited by this paper
• Gold Glyconanoparticles as Water-Soluble Polyvalent Models To Study Carbohydrate Interactions.

  2001cited by this paper
• DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.

  2000cited by this paper
• Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses.

  2000cited by this paper
• High frequency of adhesion defects in B-lineage acute lymphoblastic leukemia.

  1999cited by this paper
• Alkanethiolate Gold Cluster Molecules with Core Diameters from 1.5 to 5.2 nm: Core and Monolayer Properties as a Function of Core Size

  1998cited by this paper
• Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

  1995cited by this paper
• Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system

  1994cited by this paper
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

  1994cited by this paper
• Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes

  1992cited by this paper

• Development of Anti-Inflammatory Agents Utilizing DC-SIGN Mediated IL-10 Secretion in Autoimmune and Immune-Mediated Disorders: Bridging Veterinary and Human Health

  2025cites this paper
• Exploiting protein-glycan interactions to design precision nanoparticles to inhibit viral infections: A Review

  2025cites this paper
• Expanding the Chemical Space of Sugar Frameworks by Quaternization of the Anomeric Carbon Atom

  2025cites this paper
• Immunomodulatory Effects of Gold Nanoparticles: Impacts on Immune Cells and Mechanisms of Action

  2025cites this paper
• Surface functionalized calcium phosphate bioceramics for immunomodulatory biomaterials.

  2025cites this paper
• Toward Glycomimetic Immunomodulators: A Synthetic Dissection of Phocaeicola vulgatus Core Oligosaccharides and Their Recognition by DC-SIGN

  2025cites this paper
• Engineering immunity with nanoparticles: highlights from recent research on transplant rejection therapy.

  2024cites this paper
• An innovative method used for the identification of N-glycans on soybean allergen β-conglycinin

  2023cites this paper
• Cell and biomaterial delivery strategies to induce immune tolerance.

  2023cites this paper
• Advances in dendritic cell targeting nano-delivery systems for induction of immune tolerance

  2023cites this paper
• Investigating the Potential of Cuboidal Nanometals as Protein Subunit Vaccine Carriers In Vivo

  2023cites this paper
• Glycofullerene-AuNPs as multivalent ligands of DC-SIGN and bacterial lectin FimH: tuning nanoparticle size and ligand density.

  2023cites this paper
• Polyvalent Glycan Functionalized Quantum Nanorods as Mechanistic Probes for Shape-Selective Multivalent Lectin-Glycan Recognition

  2023cites this paper
• Biomimetic nanoparticles for DC vaccination: a versatile approach to boost cancer immunotherapy.

  2023cites this paper
• Multivalent glycosystems for human lectins.

  2022cites this paper
• Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis

  2022cites this paper
• Surface-engineered nanoparticles in cancer immune response and immunotherapy: Current status and future prospects.

  2022cites this paper
• Sulfation of Heparan and Chondroitin Sulfate Ligands Enables Cell-Specific Homing of Nanoprobes

  2022cites this paper
• Synthetic Glyconanoparticles Modulate Innate Immunity but Not the Complement System

  2022cites this paper
• Recent Developments in the Use of Glyconanoparticles and Related Quantum Dots for the Detection of Lectins, Viruses, Bacteria and Cancer Cells

  2021cites this paper
• A brief insight to the role of glyconanotechnology in modern day diagnostics and therapeutics.

  2021cites this paper
• Trehalose-based neuroprotective autophagy inducers.

  2021cites this paper
• Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting

  2020cites this paper
• Plant lectins and their usage in preparing targeted nanovaccines for cancer immunotherapy.

  2020cites this paper
• Inducing immune tolerance with dendritic cell-targeting nanomedicines

  2020cites this paper
• Interfering with the Sugar Code: Ten Years Later

  2020cites this paper
• Impact of Nanoparticles on Dendritic Cells

  2020cites this paper
• Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor Therapy

  2020cites this paper
• Key properties of AuNPs for diagnosis and phototherapy Types of AuNPs Colloidal

  2019cites this paper
• Glycans in nanomedicine, impact and perspectives.

  2019cites this paper
• Poly(lactide-co-glycolide) nanoparticles as delivery platforms for TLR7/8 agonist-based cancer vaccine

  2019cites this paper
• Glycan Carriers As Glycotools For Medicinal Chemistry Applications.

  2019cites this paper
• Development of Fluorogenic Substrates of α-l-Fucosidase Useful for Inhibitor Screening and Gene-expression Profiling.

  2019cites this paper
• The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8+ T Cell Responses

  2019cites this paper
• Poly(d,l-lactide-co-glycolide) Nanoparticles as Delivery Platforms for TLR7/8 Agonist-Based Cancer Vaccine

  2019cites this paper
• Maleimide and Cyclooctyne-Based Hexakis-Adducts of Fullerene: Multivalent Scaffolds for Copper-Free Click Chemistry on Fullerenes.

  2018cites this paper
• Design of Gold Nanoparticles in Dendritic Cell‐Based Vaccines

  2018cites this paper
• Using the glycan toolbox for pathogenic interventions and glycan immunotherapy.

  2018cites this paper
• Oxyamine Linkers for the Protecting Group Free Synthesis of Glycoconjugates

  2017cites this paper
• Recent advances in the Glyco-Gold Nanoparticles of different shapes and its potential applications

  2017cites this paper
• Five-Part Pentameric Nanocomplex Shows Improved Efficacy of Doxorubicin in CD44+ Cancer Cells

  2017cites this paper
• Targeting dendritic cells through gold nanoparticles: A review on the cellular uptake and subsequent immunological properties

  2017cites this paper
• Glycan-Based Cell Targeting To Modulate Immune Responses.

  2017cites this paper
• Gold nanoparticles enlighten the future of cancer theranostics

  2017cites this paper
• Glyco-gold nanoparticles: synthesis and applications

  2017cites this paper
• Modifying Dendritic Cell Activation with Plasmonic Nano Vectors

  2017cites this paper
• Aerosol Delivery of Functionalized Gold Nanoparticles Target and Activate Dendritic Cells in a 3D Lung Cellular Model.

  2017cites this paper
• Cell membrane-derived nanomaterials for biomedical applications.

  2017cites this paper
• Structural Characterization of Biofunctionalized Gold Nanoparticles by Ultrahigh-Resolution Mass Spectrometry

  2017cites this paper
• Expanding the library of divalent fucosidase inhibitors with polyamino and triazole-benzyl bridged bispyrrolidines.

  2016cites this paper
• Glycoconjugates and Glycomimetics as Microbial Anti-Adhesives.

  2016cites this paper
• Biomimetic strategies for targeted nanoparticle delivery

  2016cites this paper
• Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes

  2016cites this paper
• Assessing the effect of different shapes of glyco-gold nanoparticles on bacterial adhesion and infections.

  2015cites this paper
• What makes an allergen?

  2015cites this paper
• Biomimetic gold nanocomplexes for gene knockdown—will gold deliver dividends for siRNA nanomedicines?

  2015cites this paper
• Biomimetic gold nanocomplexes for gene knockdown: Will gold deliver dividends for small interfering RNA nanomedicines?

  2015cites this paper
• Thiourea‐Bridged Nanodiamond Glycoconjugates as Inhibitors of Bacterial Adhesion

  2015cites this paper
• Skin-Resident Antigen-Presenting Cells: Instruction Manual for Vaccine Development

  2013cites this paper